Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
54,009,713
-
Share change
-
+92,832
-
Total reported value
-
$6,777,439,742
-
Put/Call ratio
-
175%
-
Price per share
-
$125.49
-
Number of holders
-
267
-
Value change
-
+$6,771,060
-
Number of buys
-
130
-
Number of sells
-
111
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q2 2021
As of 30 Jun 2021,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
267 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,009,713 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Inc., Avoro Capital Advisors LLC, FMR LLC, Farallon Capital Management LLC, JANUS HENDERSON GROUP PLC, Darwin Global Management, Ltd., WELLINGTON MANAGEMENT GROUP LLP, and Artal Group S.A..
This page lists
267
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.